закрити [x]
приховати бюлетень | кошик

HQ of Swissmedic, the Swiss Agency for Therapeutic Products (10)

EN_01454672_0001
EN_01454672_0001

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM

EN_01454672_0002
EN_01454672_0002

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM

EN_01454672_0003
EN_01454672_0003

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM

EN_01454672_0004
EN_01454672_0004

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM

EN_01454672_0005
EN_01454672_0005

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM

EN_01454672_0006
EN_01454672_0006

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM

EN_01454672_0007
EN_01454672_0007

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM

EN_01454672_0008
EN_01454672_0008

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM

EN_01454672_0009
EN_01454672_0009

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM

EN_01454672_0010
EN_01454672_0010

Headquarters of Swissmedic, the Swiss Agency for Therapeutic Products, has received a third application for approval of a coronavirus vaccine from the American biotechnology company Moderna, the agency announced on Friday. Switzerland Bern, November 18, 2020. Photo by Francois Glories/ABACAPRESS.COM